The National Cardiovascular Specialty Group has representatives from all areas of the UK and has the largest portfolio of studies by specialty.
The Cardiovascular Specialty Group covers studies examining mechanisms, methods of investigation, and new treatments of diseases within the areas of: Atherosclerotic cardiovascular disease, Hypertension, Hyperlipidaemia, Vascular aspects of diabetes, Heart failure, Rhythm disturbances of the heart, Cardiomyopathy, Valvular heart disease, Congenital heart disease (excluding purely paediatric aspects), Pulmonary hypertension and other pulmonary vascular disease
Areas of overlap therefore exist with: Diabetes, Stroke/cerebrovascular disease, Surgery, Primary care, Haematology (coagulation), Respiratory medicine (PH).
The Cardiovascular Speciality Group will:
- Examine the eligibility and suitability for adoption of new studies that fall outside those automatically adopted to the portfolio.
- Have knowledge of recruitment to studies on the portfolio, identify blocks to recruitment.
- Work with their CLRN and the CCRN to remove blocks and facilitate recruitment.
- Work with the British Cardiovascular Society to help deliver the above aims.
- Establish links with the British Heart Foundation and other funders to further develop the Cardiovascular portfolio and avoid duplication within the portfolio.
Specialty Group Lead: Dr Jonathan Hill
Jonathan Hill qualified from Edinburgh University Medical School in 1992 following pre clinical training at Cambridge University. He trained in cardiology at The London Chest and St Bartholomew’s Hospitals. In 1999 he was awarded the first National Heart Lung and Blood Institute Bench to Bedside award and trained in basic science and interventional research within the Cardiovascular Branch of the National Institutes of Health in Bethesda. He completed his interventional cardiology training at the London Chest Hospital. In 2005 he was appointed, as Clinical Senior Lecturer and Consultant Cardiologist at King’s College London. He continues with his research programme relating to stem and progenitor cells in cardiovascular disease and is a practising interventional cardiologist with a special interest in acute myocardial infarction and new biological therapy.
His thesis work at National Insitutes of Health related to the development of novel assays for measuring endothelial progenitor cells and the use of magnetic resonance imaging for tracking the engraftment and trafficking of stem and progenitor cells in acute myocardial infarction. He has published a number of manuscripts in this field in high impact journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences, Circulation, Circulation Research and Blood More recently he has published on the use of cytokine mobilization in no option patients with chronic myocardial ischaemia. He is currently the co-principal investigator of a multi-centre study using selected bone marrow stem cells in patients with large myocardial infarction.
Visit the National Cardiovascular Specialty Group web page for further information.